Outlook on the Global Allergy Immunotherapy Market (2019 to 2026) - Featured Players Include Merck, Allergy Therapeutics & Anergis Among Others - ResearchAndMarkets.com

DUBLIN--()--The "Global Allergy Immunotherapy Market Analysis 2019" report has been added to ResearchAndMarkets.com's offering.

The Global Allergy Immunotherapy market is expected to reach $4.21 billion by 2026 growing at a CAGR of 12.0% during the forecast period.

Allergen immunotherapy, also termed as desensitization or hypo-sensitization, is a medical treatment aiming at patients suffering from allergies that are insufficiently controlled by symptomatic treatments. There is an increase in the prevalence of allergy and pharmacotherapy alone is insufficient to control the disease.

The allergy immunotherapeutic treatment helps increase immunological tolerance and alters the disease course. Factors such as rising prevalence of various types of allergies and launch of new sublingual immunotherapies in emerging economies are driving the market. However, the restricted healthcare spending in the underserved market of Europe will restrain the growth.

Based on the treatment, Subcutaneous Immunotherapy (SCIT) segment is likely to have a huge demand during the forecast period owing to its effectiveness to treat various allergies like asthma. It is a unique therapy for allergic disease because it provides symptomatic relief while modifying the allergic disease by targeting the underlying immunological mechanism. Its efficiency and safety have been established in the treatment of asthma, allergic rhinitis and stinging insect hypersensitivity in numerous controlled clinical trials.

Key Questions Answered in this Report:

  • How this market evolved since the year 2016
  • Market size estimations, forecasts and CAGR for all the segments presented in the scope
  • Key Market Developments and financials of the key players
  • Opportunity Analysis for the new entrants
  • SWOT Analysis of the key players
  • Fastest growing markets analysed during the forecast period

Key Topics Covered:

1 Market Synopsis

2 Research Outline

3 Market Dynamics

3.1 Drivers

3.2 Restraints

4 Market Environment

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global Allergy Immunotherapy Market, By Allergy Type

5.1 Introduction

5.2 Allergic Asthma

5.3 Allergic Rhinitis

5.4 Cat Allergy

5.5 Peanut Allergy

5.6 Venom Allergy

5.7 Food Allergy

5.8 Other Allergy Types

6 Global Allergy Immunotherapy Market, By Treatment

6.1 Introduction

6.2 Subcutaneous Immunotherapy (SCIT)

6.3 Sublingual Immunotherapy (SLIT)

6.4 Specific Immunotherapy (SIT)

7 Global Allergy Immunotherapy Market, By Distribution Channel

7.1 Introduction

7.2 Retail Pharmacy and Drug Stores

7.3 Online Pharmacy

7.4 Hospital Pharmacy

7.5 E-Commerce

7.6 Drug stores

7.7 Other Distribution Channels

8 Global Allergy Immunotherapy Market, By Geography

8.1 Introduction

8.2 North America

8.3 Europe

8.4 Asia Pacifc

8.5 South America

8.6 Middle East & Africa

9 Strategic Benchmarking

10 Vendors Landscape

10.1 HAL Allergy Group

10.2 ALK-Abello A/S

10.3 Merck KGaA

10.4 Allergy Therapeutics

10.5 Circassia

10.6 Stallergenes Greer

10.7 Hollister Allergy

10.8 DBV Technologies

10.9 Anergis

10.10 Biomay AG

10.11 Aimmune Therapeutics

10.12 Leti Pharma

For more information about this report visit https://www.researchandmarkets.com/r/v6u5cy

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900